» Articles » PMID: 36704039

Applications of Spatially Resolved Omics in the Field of Endocrine Tumors

Overview
Specialty Endocrinology
Date 2023 Jan 27
PMID 36704039
Authors
Affiliations
Soon will be listed here.
Abstract

Endocrine tumors derive from endocrine cells with high heterogeneity in function, structure and embryology, and are characteristic of a marked diversity and tissue heterogeneity. There are still challenges in analyzing the molecular alternations within the heterogeneous microenvironment for endocrine tumors. Recently, several proteomic, lipidomic and metabolomic platforms have been applied to the analysis of endocrine tumors to explore the cellular and molecular mechanisms of tumor genesis, progression and metastasis. In this review, we provide a comprehensive overview of spatially resolved proteomics, lipidomics and metabolomics guided by mass spectrometry imaging and spatially resolved microproteomics directed by microextraction and tandem mass spectrometry. In this regard, we will discuss different mass spectrometry imaging techniques, including secondary ion mass spectrometry, matrix-assisted laser desorption/ionization and desorption electrospray ionization. Additionally, we will highlight microextraction approaches such as laser capture microdissection and liquid microjunction extraction. With these methods, proteins can be extracted precisely from specific regions of the endocrine tumor. Finally, we compare applications of proteomic, lipidomic and metabolomic platforms in the field of endocrine tumors and outline their potentials in elucidating cellular and molecular processes involved in endocrine tumors.

Citing Articles

Application of multi-omics in the study of traditional Chinese medicine.

Zhao M, Che Y, Gao Y, Zhang X Front Pharmacol. 2024; 15:1431862.

PMID: 39309011 PMC: 11412821. DOI: 10.3389/fphar.2024.1431862.


Spatial proteomics: unveiling the multidimensional landscape of protein localization in human diseases.

Wu M, Tao H, Xu T, Zheng X, Wen C, Wang G Proteome Sci. 2024; 22(1):7.

PMID: 39304896 PMC: 11416001. DOI: 10.1186/s12953-024-00231-2.

References
1.
Nanba K, Omata K, Gomez-Sanchez C, Stratakis C, Demidowich A, Suzuki M . Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks. Hypertension. 2019; 73(4):885-892. PMC: 6416065. DOI: 10.1161/HYPERTENSIONAHA.118.12070. View

2.
He C, Fong L, Young S, Jiang H . NanoSIMS imaging: an approach for visualizing and quantifying lipids in cells and tissues. J Investig Med. 2016; 65(3):669-672. PMC: 5493309. DOI: 10.1136/jim-2016-000239. View

3.
Zhan X, Long Y . Exploration of Molecular Network Variations in Different Subtypes of Human Non-functional Pituitary Adenomas. Front Endocrinol (Lausanne). 2016; 7:13. PMC: 4748062. DOI: 10.3389/fendo.2016.00013. View

4.
Zhang J, Guo C, Huo X, Ma X, Li X, Abliz Z . Unsaturated lipid isomeric imaging based on the Paternò-Büchi reaction in the solid phase in ambient conditions. Talanta. 2021; 235:122816. DOI: 10.1016/j.talanta.2021.122816. View

5.
Rodrigo J, Hernandez-Prera J, Randolph G, Zafereo M, Hartl D, Silver C . Parathyroid cancer: An update. Cancer Treat Rev. 2020; 86:102012. DOI: 10.1016/j.ctrv.2020.102012. View